Published in Cancer Res on June 01, 2001
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol (2009) 1.61
Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America. Int J Cancer (2011) 1.09
Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res (2008) 1.09
Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenterol (2001) 1.09
Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer (2006) 1.07
A new Web site compiling forensic chromosome X research is now online. Int J Legal Med (2005) 0.97
Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol (2003) 0.97
A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer (2008) 0.96
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution. J Oncol (2009) 0.91
Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn (2010) 0.89
Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary. Gynecol Oncol (2014) 0.83
Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. Yonsei Med J (2008) 0.83
Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific. Int J Clin Exp Pathol (2008) 0.82
Features of ovarian cancer in Lynch syndrome (Review). Mol Clin Oncol (2014) 0.80
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist (2016) 0.78
Evaluation of microsatellite instability in women with epithelial ovarian cancer. Oncol Lett (2012) 0.77
DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation. Int J Mol Sci (2012) 0.77
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer. Anticancer Res (2012) 0.77
Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography. World J Gastroenterol (2006) 0.75
Lack of association between microsatellite instability and benign adrenal tumors. World J Surg (2006) 0.75
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 5.37
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol (2000) 3.19
Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol (1997) 2.89
Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis (1996) 2.44
Robotic radical prostatectomy in the community setting--the learning curve and beyond: initial 200 cases. J Urol (2005) 2.33
Molecular determinants of ovarian cancer plasticity. Am J Pathol (2001) 2.32
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer (1991) 2.26
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20
Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A (1992) 2.18
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res (2001) 1.99
Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol (1996) 1.89
Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol Oncol (1996) 1.87
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res (2001) 1.73
Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol (1967) 1.71
Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol (2001) 1.70
Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer (2001) 1.70
Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer (1997) 1.68
Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res (2000) 1.66
NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res (1998) 1.57
Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer (2000) 1.56
Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol (1992) 1.49
The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus. Biochem Pharmacol (1976) 1.49
What is a normal CA125 level? Gynecol Oncol (1994) 1.48
Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat (1999) 1.47
Stage IIIC ovarian leiomyosarcoma in a premenopausal woman with multiple recurrences: prolonged survival with surgical therapy. Gynecol Oncol (1997) 1.47
Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol (1993) 1.47
Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheumatol (1999) 1.46
Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci U S A (1993) 1.46
Distant metastases in ovarian cancer: association with p53 mutations. Clin Cancer Res (1999) 1.41
Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol (1995) 1.41
Malignant mixed mullerian tumor of the ovary and bilateral breast cancer: an argument for BRCA3, or a coincidental cluster of unconnected cancers? Gynecol Oncol (2003) 1.39
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood (1985) 1.39
Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys (1996) 1.36
Immunohistochemical localization of collagen types I and II in the developing chick cornea and tibia by electron microscopy. Invest Ophthalmol Vis Sci (1982) 1.34
Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol (1996) 1.34
maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res (1998) 1.32
Production and characterization of a monoclonal antibody to chicken type I collagen. Proc Natl Acad Sci U S A (1979) 1.27
RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb Symp Quant Biol (1994) 1.26
Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res (1989) 1.24
Monoclonal antibodies to connective tissue macromolecules: type II collagen. Biochem Biophys Res Commun (1980) 1.22
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene (2006) 1.22
Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis (1998) 1.22
Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res (1999) 1.21
Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev (1999) 1.21
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma. Cancer (2000) 1.20
Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol (1997) 1.19
Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer (2000) 1.19
Peroxisomes: new aspects of cell physiology and biochemistry. Physiol Rev (1977) 1.18
Guidelines work better than animal welfare law. Nature (2000) 1.16
Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother (1975) 1.16
Collagen in the egg shell membranes of the hen. Dev Biol (1984) 1.16
Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. Am J Physiol Heart Circ Physiol (2001) 1.14
Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res (1999) 1.14
Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer. Cancer (2000) 1.14
Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev (2001) 1.14
Precision measurement of the weak mixing angle in Møller scattering. Phys Rev Lett (2005) 1.13
Changes in jejunal permeability and passive permeation of sugars in intestinal biopsies in coeliac disease and Crohn's disease. Clin Sci (Lond) (1988) 1.12
Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res (1989) 1.12
Treatment of orthostatic hypotension with dihydroergotamine. Br Med J (1979) 1.10
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci (1991) 1.09
Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res (1983) 1.08
HIV infection in hospitalized patients and Medicaid enrollees: the accuracy of medical record coding. Am J Public Health (1993) 1.08
Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res (1998) 1.08
Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res (1997) 1.08
The completeness of AIDS case reporting, 1988: a multisite collaborative surveillance project. Am J Public Health (1992) 1.07
Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents. Int J Cancer (1989) 1.07
Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene (1996) 1.06
The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res (1993) 1.06
Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. Free Radic Biol Med (1999) 1.05
Maspin: a tumor suppressing serpin. Curr Top Microbiol Immunol (1996) 1.05
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Cancer (1998) 1.03
Seroprevalence of human hantavirus infection in the Ribeirão Preto region of São Paulo State, Brazil. Emerg Infect Dis (2000) 1.01
Trichloroethylene: a cardiac teratogen in developing chick embryos. Pediatr Res (1988) 1.01
L-asparaginase and PEG asparaginase--past, present, and future. Leuk Lymphoma (1993) 1.00
Progesterone-binding components of chick oviduct. VIII. Receptor activation and hormone-dependent binding to purified nuclei. J Biol Chem (1975) 1.00
Evaluating the impact of workstation usage on radiology report times in the initial 6 months following installation. J Digit Imaging (1999) 0.99
Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol (2010) 0.99
Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene (1992) 0.98
Information needs of naval primary care providers and patients at sea. Mil Med (1999) 0.97
A coralline hydroxyapatite bone graft substitute. Preliminary report. Clin Orthop Relat Res (1984) 0.96
Pregnancy following cervical conization. Am J Obstet Gynecol (1982) 0.96
Clinical and serologic evaluation of neonates for congenital syphilis: a continuing diagnostic dilemma. J Infect Dis (1993) 0.95
Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol (2000) 0.94
Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. Exp Cell Res (1991) 0.94
Maspin. A tumor suppressing serpin. Adv Exp Med Biol (1997) 0.93
Dactinomycin in the treatment of recurrent or persistent endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group. Gynecol Oncol (1999) 0.92
Progesterone-binding components of chick oviduct. IX. The kinetics of nuclear binding. J Biol Chem (1975) 0.92
De-mystifying the mechanism(s) of maspin. Nat Med (2000) 0.91
Cloning of the gene coding for a human receptor for formyl peptides. Characterization of a promoter region and evidence for polymorphic expression. Biochemistry (1992) 0.91
Drug resistance in ovarian cancer: from the laboratory to the clinic. Obstet Gynecol (1998) 0.91
Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol (2001) 0.91
The localization of enterokinase to the brush border membrane of the guinea pig small intestine. Gut (1970) 0.91
Cervical cancer: application of MR imaging in radiation therapy. Radiology (1993) 0.90
Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis. J Rheumatol (2000) 0.90
A serum-free, chemically-defined medium for function and growth of primary neonatal rat heart cell cultures. In Vitro (1983) 0.90
Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line. Biotechniques (1990) 0.90
Progesterone-binding components of chick oviduct. In vitro effect of receptor subunits on gene transcription. J Biol Chem (1976) 0.90
A well-being programme in severe mental illness. Baseline findings in a UK cohort. Int J Clin Pract (2007) 0.90